AstraZeneca commences patent infringement litigation against IVAX

13-Mar-2006

AstraZeneca announced that it has filed a lawsuit in the United States District Court for the District of New Jersey against IVAX Corporation, IVAX Pharmaceuticals, Inc. and Zenith laboratories, Inc. (collectively "IVAX"), and IVAX's parent, Teva Pharmaceutical Industries Ltd. and its U.S. subsidiary, Teva Pharmaceuticals USA, for willful infringement of AstraZeneca's patents protecting NEXIUM® (esomeprazole magnesium).

The lawsuit is in response to an Abbreviated New Drug Application filed by IVAX with the US Food and Drug Administration regarding IVAX's intent to market a generic version of AstraZeneca's NEXIUM in the US prior to the expiration of five AstraZeneca Patents: 5,714,504; 5,877,192; 6,369,085; 6,428,810; and 6,875,872. The expiration dates for these patents range from 2014 through to 2019.

Other news from the department research and development

These products might interest you

Gilson MyPIPETMAN Select and MyPIPETMAN Enterprise Pipettes

Gilson MyPIPETMAN Select and MyPIPETMAN Enterprise Pipettes by Gilson

Grab the Gilson pipettes with your name and favorite colors!

Customise Your Pipettes to Fit Your Research

pipettes
Systec H-Series

Systec H-Series by Systec

Safe, reproducible and validatable sterilization of liquids, solids and waste

Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications

laboratory autoclaves
Whatman™ folded filter papers

Whatman™ folded filter papers by Cytiva

Whatman folded filter papers

Convenient folded formats speed up your sample preparation

filter papers
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance